Mast Cell Leukemia — Trials

Mast Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03214666	GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies	terminated	Phase 1 / Phase 2	12	GT Biopharma, Inc.INDUSTRY	1	Nov 10, 2022	clinicaltrials
NCT02415608	Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis	terminated	Phase 2	4	Jason Robert GotlibOTHER	1	Sep 20, 2018	clinicaltrials
NCT00387426